2 mn read“Virtual The 14th Liver Update and The Annual Scientific Meeting of Ina ASL/PPHI 2022” symposium is organized by Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital and Indonesian Association for the Study of the Liver (Ina ASL/PPHI).
2 mn readJakarta, – PT Kalbe Farma Tbk (Kalbe) bekerja sama dengan Peneliti Hati Indonesia (PPHI) mengadakan kampanye dan edukasi kesehatan
2 mn readDalam rangka peringatan hari Hepatitis sedunia 2015 yang jatuh pada 28 Juli 2015, KEMENKES yang diwakili oleh Direktur Penanggulangan Penyakit Menular Langsung (PPML), Dr. Sigit
2 mn readBasic Course of Chronic Hepatitis C Management is an educational attempt designed for expanding the reach in hepatitis C management with focus on internist in
2 mn readDate: March 4-8, 2020City: Bali, IndonesiaPresident: Dr. Rino Gani Website : HereRegistrasi : Here Download Second Announcement : Here
2 mn readTingginya angka kejadian hepatitis di Indonesia dan rendahnya pengetahuan masyarakat akan penyakit ini membuat Perhimpunan Peneliti Hati Indonesia (PPHI)
2 mn readDate: March 4-8, 2020City: Bali, IndonesiaPresident: Dr. Rino GaniWebsite : HereRegistrasi : Here Download Second Announcement : Here
< 1 mn readHCC Academy of Immunotherapy (Ina-CIT): Clinician roles to change HCC patient’s outcomes in Cancer Immunotherapy Era, conducted on 01 October 2022, 09:30 AM, at Mandarin
< 1 mn readUntuk memudahkan para hepatolog mencari segala informasi terkait penyakit hati, jurnal, dan update event PPHI serta untuk para anggota saling berkomunikasi, tim PPHI meluncurkan kembali
2 mn read“Virtual The 14th Liver Update and The Annual Scientific Meeting of Ina ASL/PPHI 2022” symposium is organized by Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo National General Hospital and Indonesian Association for the Study of the Liver (Ina ASL/PPHI).
< 1 mn readClinical Associate Prof Tai Wai Meng David was giving his presentation on Implications of Immunotherapy Data in Unresectable HCC. There were three highlights from his session:
< 1 mn readAbstract Hepatocellular carcinoma (HCC) is a deadly cancer with a rising incidence in the last 20 years. Most patients are diagnosed late when curative treatment